Morphology of the human cardiac valves of inflammatory and non-inflammatory genesis of the aquired heart defects
DOI:
https://doi.org/10.11603/bmbr.2706-6290.2022.3.13179Keywords:
heart, endocardium, endothelial function, structural changesAbstract
Summary. The prosthetics of the heart valves was and remains one of the main parts of cardiac surgery. Reliable information about the nature of valve heart defects will be useful for developing the most effective treatment regimens for patients.
The aim of the study – to investigate morphological peculiarities of the heart valves, which were removed during the surgical replacement of their prostheses.
Materials and Methods. The material for the morphological study of the valves was taken in the Institute of Cardiovascular Surgery named after M. M. Amosov. There were studied the main structural components of 855 valves (377 mitral and 478 aortic ones). Out of the cusps, chordae and papillary muscles, according to the generally accepted method, there were made histological specimens, which were stained with hematoxylin-eosin, with picrofuchsin according to Van Gieson method, Weigert resorcin-fuchsin method and also according to MSB method in Zerbino-Lukasevich modification. Frozen sections were processed by means of Sudan to identify adipose cells.
Results. There was revealed the predominance of lesions of the aortic valve. The frequency of pathological processes causing acquired heart defects has been clarified. The analysis of structural changes revealed the predominance of lipoidosis in the group of non-inflammatory valve damage. When estimating the specific gravity of lipoidosis in 46.4 %, it was combined with rheumatism, infectious endocarditis, dysplasia, and myxomatous degeneration.
Conclusions. Morphological analysis of the surgical specimen showed that acquired heart defects are some polymorphic pathologies. In the foreground among the causes of defects there is rheumatic valvulitis (49.7 %), in the second place – non-inflammatory valve damage (38.4 %), in the third place – infective endocarditis (10.4 %). Acquired heart defects, caused by one of the above-mentioned reasons, are often complicated as a result of the layering of changes that are associated with hemodynamic trauma of the endocardium or lipoidosis. Cholesterol necrosis of the cusps is the basis for the development of infective endocarditis.
References
Bocchi EA, Guimarães G, Tarasoutshi F, Spina G, Mangini S, Bacal F. Cardiomyopathy, adult valve disease and heart failure in South America. Heart. 2009;95(3): 181-9.
Kovalenko VM, Nesukay OH. Diagnosis and treatment of valve heart defects. Ukrainian Journal of Rheumatology. 2012;3(49): 27-39.
Lamelas J, Aberle CM, Gnanashanmugam S. Innovative Approaches to Mitral Valve Repair and Replacement. In: Carabello BA, editor. Valvular Heart Disease. London: Springer London; 2020.
Li RL, Russ J, Paschalides C. Mechanical considerations for polymeric heart valve development: biomechanics, materials, design and manufacturing. Biomaterials 2019;225: 119493.
Marom G, Bluestein D. Lagrangian methods for blood damage estimation in cardiovascular devices--How numerical implementation affects the results. Expert Rev Med Devices. 2016;13: 113-22. DOI:10.1586/17434440.2016.1133283.
Marom Gil, Einav Shmuel. New insights into valve hemodynamics. Rambam Maimonides Med J. 2020;11(2): e0014. Published online 2020 Apr 29.
DOI: 10.5041/RMMJ.10400
Rausch MK, Zollner AM, Genet M, Baillargeon B, Bothe W, Kuhl E. A virtual sizing tool for mitral valve annuloplasty. Int J Numer Method Biomed Eng. 2017;33: e02788. DOI:10.1002/cnm.2788.
Vukicevic M, Vekilov DP, Grande-Allen JK, Little SH. Patient-specific 3D valve modeling for structural intervention. Struct Heart. 2017;1: 236-48.
DOI:10.1080/24748706.2017.1377363.
Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al.Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med. 2017;377(8): 713-22.
Zhang BL, Bianco RW, Schoen FJ. Preclinical assessment of cardiac valve substitutes: current status and considerations for engineered tissue heart valves. Front Cardiovasc Med. 2019;6: 72.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Bulletin of Medical and Biological Research

This work is licensed under a Creative Commons Attribution 4.0 International License.